Back to search

Πανεπιστήμιο Μακεδονίας

A study of firm's competitiveness: R and D and profitability in the Greek pharmaceutical industry

Abstract

dc:description

The aim of this dissertation is to determine the factors that affect the firm competitiveness of Greek pharmaceutical Industry which produce branded generics and include in-house R&D sections for the period 1998-2016. Greek pharmaceutical industry is one of the most dynamic in the Greek manufacturing sector and its contribution affects considerably the Greek economy as a whole. The concept of firm competitiveness provided the theoretical framework of the study. It has been presented a plethora of definitions about firm competitiveness and techniques for its measuring addressing an overall analysis. The major variable under investigation is the innovation or otherwise R&D expenditures and its impact on firm competitiveness. In order to conclude in accurate results, more variables have been included. In addition, profitability has been used as a proxy of firm competitiveness. Two profitability equations have been constructed and three econometric techniques have been used for the econometric analysis. Data sample consist of 246 total observations. Results reveal the crucial role of R&D intensity ratio and the effect of the other determinants on the profitability and by extension in firm competitiveness. The study closes with the policy implication and suggestions for further research

Degree

thesis:*
Grantor dc:publisher
Πανεπιστήμιο Μακεδονίας
Year dc:date
2021

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Kounnou, Vasiliki
  • Κούννου, Βασιλική

Subjects

dc:subject × 14

Rights

Language dc:language
eng

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/50211

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Kounnou, Vasiliki; Κούννου, Βασιλική. A study of firm's competitiveness: R and D and profitability in the Greek pharmaceutical industry. Πανεπιστήμιο Μακεδονίας, 2021. http://hdl.handle.net/10442/hedi/50211